N

NeuroSense Therapeutics Ltd
D

NRSN

1.31000
USD
0.01
(0.77%)
مغلق
حجم التداول
503
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
25,507,018
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: NeuroSense Therapeutics Ltd

القطاع: Healthcare
الصناعة: Biotechnology
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.